Freeline Therapeutics Holdings Plc Adss (FRLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2017 | |
| Operating Expenses | 98,447 | 142,379 | 102,449 | 63,644 | 0 |
| Operating Income | -98,447 | -142,379 | -102,449 | -63,644 | N/A |
| Other Income | 9,843 | 2,330 | 6,256 | 9,876 | 0 |
| Pre-tax Income | -88,604 | -140,049 | -96,193 | -53,768 | 0 |
| Income Tax | 368 | 342 | 129 | 141 | N/A |
| Net Income Continuous | -88,972 | -140,391 | -96,322 | -53,909 | N/A |
| Net Income | $-88,972 | $-140,391 | $-96,322 | $-53,909 | $N/A |
| EPS Basic Total Ops | -22.39 | -58.66 | -101.64 | -126.72 | N/A |
| EPS Basic Continuous Ops | -22.40 | -58.69 | -101.58 | -126.75 | N/A |
| EPS Diluted Total Ops | -22.39 | -58.66 | -101.64 | -126.72 | N/A |
| EPS Diluted Continuous Ops | -22.40 | -58.69 | -101.58 | -126.75 | N/A |
| EPS Diluted Before Non-Recurring Items | -22.39 | -58.66 | -101.64 | N/A | N/A |
| EBITDA(a) | $-96,706 | $-139,989 | $-100,536 | $-62,104 | $N/A |